Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade

Area of Science:

• Immunology
• Cancer Biology
• Tumor Microenvironment

Background:

• Immune checkpoint inhibitors (ICIs) show limited efficacy in many solid tumors.
• Understanding the cellular basis of antitumor immunity is crucial for improving ICI therapy.

Purpose of the Study:

• To identify and characterize novel multicellular immune structures involved in antitumor immunity.
• To investigate the role of these structures in response to immune checkpoint blockade.

Main Methods:

• Multiplexed imaging and spatial transcriptomics in mouse and human tumors.
• Analysis of cellular composition and spatial organization within tumors.
• Assessment of the ICOS-ICOSL pathway's role in immune cell interactions.
• Correlation of tetrad formation with clinical response in bladder cancer patients.

Main Results:

• A novel multicellular immune unit, termed 'tetrads' (macrophages, cDC1s, CD4+ T-cells, CD8+ T-cells), was identified.
• Tetrads assemble early, depend on the ICOS-ICOSL pathway, and contain specific immune cell subsets.
• CD8+ T-cells within tetrads are activated, and associated macrophages support T-cell function.
• Tetrad formation, not triads or dyads, correlates with clinical response in bladder cancer patients treated with ICIs.

Conclusions:

• Tetrads represent a fundamental cellular architecture coordinating antitumor immunity.
• Tetrads are essential for effective tumor eradication and predict response to immune checkpoint inhibitors.
• Targeting tetrad formation may enhance ICI efficacy in solid tumors.